Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study
ClinicalTrials.gov study NCT03110510. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine
ClinicalTrials.gov study NCT00294385. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma
ClinicalTrials.gov study NCT04833582. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer
ClinicalTrials.gov study NCT00754351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT02981719. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00530634. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
ClinicalTrials.gov study NCT06855225. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC
ClinicalTrials.gov study NCT02992340. IPD Sharing: NO. Countries: 3. Publications: 0.
Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00090909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00173888. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT07076212. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
ClinicalTrials.gov study NCT06597565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT00436800. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
ClinicalTrials.gov study NCT00003744. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metast
ClinicalTrials.gov study NCT06364904. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer
ClinicalTrials.gov study NCT02054338. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Salvage mFOLFOX in BTC After Failure of Gemcitabine
ClinicalTrials.gov study NCT01127555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer
ClinicalTrials.gov study NCT00270582. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT03908333. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00191347. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.